Sana Biotechnology, Inc. (SANA)

NASDAQ: SANA · Real-Time Price · USD

3.330

+0.180 (5.71%)

At close: Mar 9, 2026, 4:00 PM EDT

3.340

+0.010 (0.30%)

After-hours: Mar 9, 2026, 6:18 PM EDT

Sana Biotechnology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2018
Selling, General & Admin	44.3	64.04	73.3	67.06	50.41	Upgrade
Research & Development	146.66	207.43	253.6	204.37	274.66	Upgrade
Operating Expenses	190.96	271.47	326.9	271.43	325.07	Upgrade
Operating Income	-190.96	-271.47	-326.9	-271.43	-325.07	Upgrade
Interest & Investment Income	3.85	10.47	9.94	3.76	0.68	Upgrade
Other Non Operating Income (Expenses)	4.61	-0.01	-0.05	-0.67	0.31	Upgrade
EBT Excluding Unusual Items	-182.51	-261.01	-317.01	-268.34	-324.09	Upgrade
Asset Writedown	-46.91	-6.39	-7.01	-4.5	-	Upgrade
Other Unusual Items	-14.75	0.64	40.77	3.36	-31.84	Upgrade
Pretax Income	-244.17	-266.76	-283.26	-269.48	-355.93	Upgrade
Net Income	-244.17	-266.76	-283.26	-269.48	-355.93	Upgrade
Net Income to Common	-244.17	-266.76	-283.26	-269.48	-355.93	Upgrade
Shares Outstanding (Basic)	253	231	195	188	166	Upgrade
Shares Outstanding (Diluted)	253	231	195	188	166	Upgrade
Shares Change (YoY)	9.68%	18.68%	3.29%	13.16%	1178.88%	Upgrade
EPS (Basic)	-0.96	-1.16	-1.46	-1.43	-2.14	Upgrade
EPS (Diluted)	-0.96	-1.16	-1.46	-1.43	-2.14	Upgrade
Free Cash Flow	-144.77	-256.58	-273.61	-310.93	-280.92	Upgrade
Free Cash Flow Per Share	-0.57	-1.11	-1.41	-1.65	-1.69	Upgrade
EBITDA	-178.21	-255.97	-309.36	-255.8	-314	Upgrade
D&A For EBITDA	12.75	15.5	17.54	15.63	11.07	Upgrade
EBIT	-190.96	-271.47	-326.9	-271.43	-325.07	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.